2 months Raymond James & Associates Sells 71,201 Shares of Amgen Inc. (NASDAQ:AMGN) MarketBeat
Raymond James & Associates decreased its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 6.7% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 989,504 shares of the medical resea…
Amgen (AMGN) · Nasdaq 100 · Science
X